Related Experiment Video
Updated: Feb 2, 2026

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres
Published on: February 2, 2015
Congenital Glaucoma: a Novel Ocular Manifestation of Hajdu-Cheney Syndrome
Insights
Hajdu-Cheney Syndrome (HCS) is a rare genetic disorder. This study identifies congenital glaucoma as a novel early HCS symptom and describes a new NOTCH2 mutation, advancing understanding of this complex condition.
Area of Science:
- Genetics
- Rare Diseases
- Ophthalmology
Background:
- Hajdu-Cheney Syndrome (HCS) is a rare multisystem disorder characterized by acro-osteolysis, severe osteoporosis, short stature, facial dysmorphism, neurological, cardiovascular, and renal abnormalities.
- HCS is typically caused by truncating mutations in NOTCH2 exon 34, leading to a stable, truncated NOTCH2 protein and enhanced Notch signaling.
Observation:
- This report details an infant with severe HCS manifestations, including congenital glaucoma as a significant, previously unreported early feature.
- The patient harbors a novel missense mutation in NOTCH2, distinct from previously identified truncating mutations.
Findings:
- The study identifies congenital glaucoma as a new ophthalmological manifestation of Hajdu-Cheney Syndrome.
- A novel, potentially pathogenic missense mutation in NOTCH2 is described, requiring further functional validation.
- This case expands the known phenotypic spectrum of HCS and its associated genetic underpinnings.
Implications:
- The findings suggest a potential role for Notch signaling in the development of the anterior chamber of the eye.
- This research may inform future diagnostic approaches and therapeutic strategies for HCS and related disorders.
- Understanding novel NOTCH2 mutations contributes to the broader knowledge of skeletal dysplasias and developmental abnormalities.
Abstract:
Hajdu-Cheney Syndrome (HSC) is a rare multisystem disease in which the phenotype involves acro-osteolysis, severe osteoporosis, short stature, wormian bones, facial dysmorphism, central neurological abnormalities, cardiovascular defects, and polycystic kidneys. We describe an infant with severe manifestations of HCS in whom congenital glaucoma was a significant early feature, which has not been reported to date. HCS cases reported to date have involved truncating mutations in exon 34 of NOTCH2 upstream the PEST domain that lead to the development of a truncated and stable NOTCH2 protein which upregluates notch signaling. We describe a hitherto undescribed missense mutation that is predicted to be pathogenic, with functional characterization remaining to be performed. Serpentine fibula-polycystic kidney syndrome (SFPKS) is allelic to HCS and commonly associated with missense NOTCH2 mutations. Our patient provides new ophthalmological manifestations of HCS and provides insight into the potential role of notch signaling in the anterior chamber development.
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Acute Pancreatitis II: Clinical Manifestations and Management
Angina III: Clinical Manifestations and Assessment

